The effect of Ergobromocriptine treatment on serum testosterone and prolactin levels in 15 patients with prostatic carcinoma and 15 patients with benign prostatic hyperplasia was examined. The prolactin levels which were elevated in patients with prostatic carcinoma showed a significant decrease after suppression with Ergobromocriptine. The selective effect of Ergobromocriptine on prolactin levels of patients with prostatic carcinoma may control the progression of the disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF02082651 | DOI Listing |
Publication Analysis
Top Keywords
prolactin levels
16
levels patients
12
patients prostatic
12
prostatic carcinoma
12
serum testosterone
8
testosterone prolactin
8
patients
5
ergobromocriptine
4
ergobromocriptine serum
4
prolactin
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!